ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00530114
Recruitment Status : Completed
First Posted : September 17, 2007
Last Update Posted : March 14, 2016
Sponsor:
Information provided by (Responsible Party):
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2008
  Actual Study Completion Date : February 2009
  Certification/Extension First Submitted : February 16, 2016